Urinary symptoms as a predictor for participation in prostate cancer screening among African American men

Prostate

Volumn 37, Issue 4, 1998, Pages 215-222

  Weinrich, Sally P ^a   Weinrich, Martin ^a   Mettlin, Curtis ^b   Reynolds Jr , William A ^a   Wofford, John E ^c  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c Columbia Urological Associates ^*  (United States)

Author keywords

African American men; Prostatic neoplasms; Screening; Urinary symptoms

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER SCREENING; CANCER STAGING; EARLY DIAGNOSIS; EDUCATION; FEMALE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MARRIAGE; MICTURITION DISORDER; NEGRO; PATIENT EDUCATION; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; SELF REPORT;

ADULT; AFRICAN AMERICANS; AGED; FORECASTING; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; PHYSICAL EXAMINATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECTUM; UROLOGIC DISEASES;

EID: 0031757316     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19981201)37:4<215::AID-PROS2>3.0.CO;2-S     Document Type: Article

References (40)

1. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM: The prevalence of prostatism: A population-based survey of urinary symptoms. J Urol 1993;150:85-89.
2. Girman CJ, Jacobsen SJ, Guess HA, Oesterling JE, Chute CG, Panser LA, Lieber MM: Natural history of prostatism: Relationship among systems, prostate volume and peak urinary flow rate. J Urol 1995;153:1510-1515.
3. Guess HA, Arrigihi HM, Metter EJ, Forzard JL: Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate 1990;17:241-246.
4. Hunter DJ, Berra-Unamuno A, Martin-Gordo A: Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years of age or older. J Urol 1996;155:1965-1970.
5. Moon TD, Brannan W, Stone NN, Ercole C, Crawtord ED, Chodak G, Brawer M, Heisey D, Bruskewitz RC: Effect of age, educational status, ethnicity and geographic location on prostate symptom scores. J Urol 1994;152:1498-1500.
6. Sagnier PP, MacFarlane G, Richard F, Botto H, Teillac P, Boyle P: Results of an epidemiological survey using a modified American Urological Association Symptom Index for benign prostatic hyperplasia in France. J Urol 1994;151:1266-1270.
7. Sagnier PP, MacFarlane G, Teillac P, Botto H, Richard F, Boyle P: Impact of symptoms of prostatism on level of bother and quality of life in the French community. J Urol 1995;669-673.
8. Tsukamoto T, Kumamoto Y, Masumori, N, Miyake H, Rhodes T, Girman CJ, Guess HA, Jacobsen SJ, Lieber MM: Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. J Urol 1995;51:391-395.
9. Jacobsen SJ, Girman CJ, Guess HA, Panser LA, Chute CG, Oesterling JE, Lieber MM: Do prostate size and urinary flow rates predict health care-seeking behavior for urinary symptoms in men? Urology 1995;45:64-69.
10. Powell IJ, Heilbrun L, Litturp PL, Franklin A, Parzuchowski J, Gelfand D, Sakr W: Outcome of African American men screened for prostate cancer: The Detroit Education and Early Detection Study. J Urol 1997;158:146-149.
11. Stenner J, DeAntoni EP, O'Donnell C, Stone NN, McLeod DG, Crawford ED: Prevalence and natural history of urinary symptoms in a longitudinal national prostate cancer screening (community-based) study. Prostate Cancer Prostatic Dis, in press.
12. Kane R, Littrup P, Babaian R, Drago JR, Less F, Chesley A, Murphy GP, Mettlin C: Prostate-specific antigen levels in 1695 men without evidence of prostate cancer. Cancer 1992;69:1201-1207.
13. Mettlin C, Murphy GP, Babian RJ, Chesley A, Kane RA, Littrup PJ, Mostofi FK, Ray PS, Shanberg AM, Toi A: The results of a five-year early prostate cancer detection intervention. Cancer 1996;77:150-159.
14. Catalona W, Richie J, Ahmann F, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men. J Urol 1994;151:1283-1290.
15. Richardson TD, Oesterling JE: Age-specific reference ranges for serum prostate specific antigen. Urol Clin North Am 1997;24: 339-351.
16. Kosary CL, Reis LA, Miller BA, Hankey BF, Harras A, Edwards BK: "SEER Cancer Statistics Review, 1973-1992: Tables and Graphs." National Cancer Institute, 1995.
17. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, Lange PH: Screening for prostatic carcinoma with prostate specific antigen. J Urol 1992;147:841-845.
18. Catalona WJ, Smith DJ, Ratliff T, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;324:1156-1161.
19. DeAntoni EP: Eight years of "Prostate Cancer Awareness Week." Cancer 1997;80:1845-1851.
20. Mettlin C, Lee F, Drago J, Murphy GP: The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer 1991; 67:2949-2958.
21. Catalona W, Richie J, Ahmann F, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men. J Urol 1994;151:1283-1290.
22. Gohagan JK, Prorok PC, Kramer BS, Hayes RB, Cornett JE: The prostate, lung, colorectal, and ovarian screening trial of the National Cancer Institute. Cancer 1994;152:1905-1909.
23. Weinrich SP, Weinrich MC, Boyd MD, Mettlin C: Increasing prostate cancer screening in African American men with peer educator and client navigator educational interventions. J Cancer Edu, in press.
24. Weinrich SP, Boyd MD, Bradford D, Mossa MS, Weinrich M: Recruitment of African-American men into prostate cancer screening. Cancer Pract 1998;6:23-30.
25. Weinrich SP, Weinrich MC, Stromborg MF, Boyd MD, Weiss HL: Using elderly educators to increase colorectal cancer screening. Gerontologist 1993;33:491-496.
26. DeAntoni EP, Crawford ED: Prostate Cancer Awareness Week. Cancer Suppl 1995;75:1874-1879.
27. SAS Institute, Inc.: "SAS/STAT User's Guide, Version 6, Fourth Edition." Cary, NC: SAS Institute, Inc., 1989.
28. Mausner J, Kramer S: "Mausner and Bahn Epidemiology - An Introductory Text." Philadelphia: W.B. Saunders Company, 1985.
29. Mettlin CJ, Murphy GP, McGinnis LS, Menck HR: The National Cancer Data Base report on prostate cancer. American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1995;76:1104-1112.
30. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT: The American Urological Association Symptom Index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148:1549-1557.
31. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Leiber MM: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 1993;270:860-864.
32. DeAntoni EP, Crawford ED, Oesterling JE, Ross CA, Berger ER, McLeod DG, Staggers F, Stone NN: Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study. Urology 1996;48:234-239.
33. Schroder FH, Denis LJ, Kirkels W, deKoning HJ, Standaert B: European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam pilot studies. Cancer 1995;76:129-134.
34. Powell IJ, Gelfand DE, Parzuchowski J, Heilburn L, Franklin A: A successful recruitment process of African American men for early detection of prostate cancer. Cancer 1995;75:1880-1884.
35. Stone NN, DeAntoni EP, Crawford ED, Prostate Cancer Education Council: Screening for prostate cancer by digital rectal examination and prostate-specific antigen: Results of Prostate Cancer Awareness Week, 1989-1992. Urol Symp 1994;44:18-25.
36. Mettlin C: Early detection of prostate cancer following repeated examinations by multiple modalities: Results of the American Cancer Society National Prostate Cancer Detection Project. Clin Invest Med 1993;16:440-447.
37. Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez JL, Emond J: Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol 1992;147:846-852.
38. Vijayakumar S, Weichselbaum R, Vaida F, Dale W, Hellman S: Prostate-specific antigen levels in African Americans correlate with insurance status as an indicator of socioeconomic status. Cancer J Sci Am 1996;2:225-233.
39. Mettlin C, Murphy G: Why is the U.S. prostate cancer death rate declining? Cancer 1998;82:249-251.
40. Eyre H, Feldman G: Status report on prostate cancer in African Americans: a national blueprint for action. CA 1998;48:315-319.